Inhibitory Effects of Propenone Derivatives on ![]() |
Park, Su-Young
(College of Pharmacy, Yeungnam University)
Kim, Kyoung-Jin (College of Pharmacy, Yeungnam University) Lee, Jong-Suk (College of Pharmacy, Yeungnam University) Lee, Eung-Seok (College of Pharmacy, Yeungnam University) Kim, Jung-Ae (College of Pharmacy, Yeungnam University) |
1 | Schreiber, S., Campieri, M., Colombel, J. F., Van Deventer, S. J., Feagan, B., Fedorak, R., Forbes, A., Gassull, M., Gendre, J. P., Van Hogezand, R. A., Lofberg, R., Modigliani, R., Pallone, F., Petritsch, W., Prantera, C., Rampton, D., Seibold, F., Vatn, M., Zeitz, M. and Rutgeerts, P. : Use of anti-tumour necrosis factor agents in inflammatory bowel disease. Int. J. Colorectal. Dis. 16, 1 (2001) |
2 | Kim, Y. S., Kim, J. S., Jung, H. C. and Song, I. S. : The effects of thalidomide on the stimulation of NF-kappaB activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line. Mol. Cells 17, 210 (2004) |
3 | Reinecker, H. C., Loh, E. Y., Ringler, D. J., Mehta, A., Rombeau, J. L. and MacDermott, R. P. : Monocytechemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108, 40 (1995) |
4 | Daig, R., Andus, T., Aschenbrenner, E., Falk, W., Scholmerich, J. and Gross, V. : Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut. 38, 216 (1996) |
5 | Van Grevenstein, W. M. U., Hofland, L. J., Van Rossen, M. E. E., Van Koetsveld, P. M., Jeekel, J. and Van Eijck, C. H. J. : Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig. Dis. Sci. 52, 2775 (2007) |
6 | MacDermott, R. P. : Alterations of the mucosal immune system in inflammatory bowel disease. J. Gastroenterol. 31, 907 (1996) |
7 | Panja, A., Goldberg, S., Eckmann, L., Krishen, P. and Mayer, L. : The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J. Immunol. 161, 3675 (1998) |
8 | Lee, E. S., Ju, H. K., Moon, T. C., Lee, E., Jahng, Y., Lee, S. H., Son, J. K., Baek, S. H. and Chang, H. W. : Inhibition of nitric oxide and tumor necrosis factor-alpha (TNF-alpha) production by propenone compound through blockade of nuclear factor (NF)-kappa B activation in cultured murine macrophages. Biol. Pharm. Bull. 27, 617 (2004) |
9 | Zareie, M., Singh, P. K., Irvine, E. J., Sherman, P. M., McKay, D. M. and Perdue, M. H. : Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am. J. Pathol. 158, 1101 (2001) DOI ScienceOn |
10 | Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A. and Sartor, R. B. : Curcumin blocks cytokinemediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J. Immunol. 163, 3474 (1999) |
11 | Aljada, A., Ghanim, H., Saadeh, R. and Dandona, P. : Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J. Clin. Endocrinol. Meta. 86, 450 (2001) |
12 | Hohensinner, P. J., Kaun, C., Rychli, K., Niessner, A., Pfaffenberger, S., Rega, G., Martin, R., Maurer, G., Ullrich, R., Huber, K. and Wojta, J. : Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-alpha via an NF-kappaB dependent mechanism. J. Thromb. Haemost. 5, 2520 (2007) |
13 | Izzo, R. S., Witkon, K., Chen, A. I., Hadjiyane, C., Weinstein, M. I. and Pellecchia, C. : Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am. J. Gastroenterol. 87, 1447 (1992) |
14 | Kang, D. G., Moon, M. K., Lee, A. S., Kwon, T. O., Kim, J. S. and Lee, H. S. : Cornuside suppresses cytokine-induced proinflammatory and adhesion molecules in the human umbilical vein endothelial cells. Biol. Pharm. Bull. 30, 1796 (2007) |
15 | Mazzucchelli, L., Hauser, C., Zgraggen, K., Wagner, H., Hess, M., Laissue, J. A. and Mueller, C. : Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am. J. Pathol. 144, 997 (1994) |
16 | Neurath, M. F., Fuss, I., Schurmann, G., Pettersson, S., Arnold, K., Muller-Lobeck, H., Strober, W., Herfarth, C. and Buschenfelde, K. H. : Cytokine gene transcription by NFkappa B family members in patients with inflammatory bowel disease. Ann. NY Acad. Sci. 17, 149 (1998) |
17 | Begue, B., Wajant, H., Bambou, J, C., Dubuquoy, L., Siegmund, D., Beaulieu, J. F., Canioni, D., Berrebi, D., Brousse, N., Desreumaux, P., Schmitz, J., Lentze, M. J., Goulet, O., Nadine, C. B. and Ruemmele, F. M. : Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130, 1962 (2006) |
18 | Grimm, M. C., Elsbury, S. K., Pavli, P. and Doe, W. F. : Interleukin 8: cells of origin in inflammatory bowel disease. Gut. 38, 90 (1996) |
19 | Lee, E. S., Park, B. C., Paek, S. H., Lee, Y. S., Basnet, A., Jin, D. Q., Choi, H. G., Yong, C. S. and Kim, J. A. : Potent analgesic and anti-inflammatory activities of 1-furan-2-yl-3-pyridin-2-ylpropenone with gastric ulcer sparing effect. Biol. Pharm. Bull. 29, 361 (2006) |
![]() |